Kahn RS - Search Results

1

Sympathetic activity and hypothalamo-pituitary-adrenal axis activity during sleep in post-traumatic stress disorder: a study assessing polysomnography with simultaneous blood sampling.

van Liempt S, Arends J, Cluitmans PJ, Westenberg HG, Kahn RS, Vermetten E. van Liempt S, et al. Among authors: kahn rs. Psychoneuroendocrinology. 2013 Jan;38(1):155-65. doi: 10.1016/j.psyneuen.2012.05.015. Epub 2012 Jul 7. Psychoneuroendocrinology. 2013. PMID: 22776420 Clinical Trial.

2

Psychopharmacology of anxiety disorders: on the role of serotonin in the treatment of anxiety states and phobic disorders.

Westenberg HG, den Boer JA, Kahn RS. Westenberg HG, et al. Among authors: kahn rs. Psychopharmacol Bull. 1987;23(1):145-9. Psychopharmacol Bull. 1987. PMID: 3110855 Clinical Trial. No abstract available.

3

Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.

den Boer JA, Westenberg HG, Kamerbeek WD, Verhoeven WM, Kahn RS. den Boer JA, et al. Among authors: kahn rs. Int Clin Psychopharmacol. 1987 Jan;2(1):21-32. doi: 10.1097/00004850-198701000-00002. Int Clin Psychopharmacol. 1987. PMID: 3117876 Clinical Trial.

4

L-5-hydroxytryptophan in the treatment of anxiety disorders.

Kahn RS, Westenberg HG. Kahn RS, et al. J Affect Disord. 1985 Mar-Apr;8(2):197-200. doi: 10.1016/0165-0327(85)90046-1. J Affect Disord. 1985. PMID: 3157732

5

Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo.

Kahn RS, Westenberg HG, Verhoeven WM, Gispen-de Wied CC, Kamerbeek WD. Kahn RS, et al. Int Clin Psychopharmacol. 1987 Jan;2(1):33-45. doi: 10.1097/00004850-198701000-00003. Int Clin Psychopharmacol. 1987. PMID: 3312397 Clinical Trial.

6

Zimeldine treatment of obsessive-compulsive disorder. Biological and neuropsychological aspects.

Kahn RS, Westenberg HG, Jolles J. Kahn RS, et al. Acta Psychiatr Scand. 1984 Mar;69(3):259-61. doi: 10.1111/j.1600-0447.1984.tb02493.x. Acta Psychiatr Scand. 1984. PMID: 6231806

7

The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder.

van Megen HJ, Westenberg HG, Den Boer JA, Kahn RS. van Megen HJ, et al. Among authors: kahn rs. Eur Neuropsychopharmacol. 1996 Aug;6(3):187-94. doi: 10.1016/0924-977x(96)00018-1. Eur Neuropsychopharmacol. 1996. PMID: 8880078 Clinical Trial.

8

Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients.

van Berckel BN, Hijman R, van der Linden JA, Westenberg HG, van Ree JM, Kahn RS. van Berckel BN, et al. Among authors: kahn rs. Biol Psychiatry. 1996 Dec 15;40(12):1298-300. doi: 10.1016/S0006-3223(96)00311-3. Biol Psychiatry. 1996. PMID: 8959296 Clinical Trial. No abstract available.

9

Cholecystokinin in anxiety.

van Megen HJ, Westenberg HG, den Boer JA, Kahn RS. van Megen HJ, et al. Among authors: kahn rs. Eur Neuropsychopharmacol. 1996 Nov;6(4):263-80. doi: 10.1016/s0924-977x(96)00038-7. Eur Neuropsychopharmacol. 1996. PMID: 8985709 Review.

10

The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients.

Scheepers FE, Gispen-de Wied CC, Westenberg HG, Kahn RS. Scheepers FE, et al. Among authors: kahn rs. Neuropsychopharmacology. 2001 Oct;25(4):468-75. doi: 10.1016/S0893-133X(01)00250-0. Neuropsychopharmacology. 2001. PMID: 11557160 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,127 results

Search Page